3.25.1 html 99 231 1 false 37 0 false 6 false false R1.htm 100000 - Document - Cover Page Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DocumentCoverPage Cover Page Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveIncomeLoss Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Mezzanine Equity and Shareholders' Equity (Deficit) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfMezzanineEquityAndShareholdersEquityDeficit Condensed Consolidated Statements of Mezzanine Equity and Shareholders' Equity (Deficit) Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995457 - Disclosure - The Company Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureTheCompany1 The Company Notes 9 false false R10.htm 995467 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1 Summary of Significant Accounting Policies Notes 10 false false R11.htm 995487 - Disclosure - Revenue Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureRevenue Revenue Notes 11 false false R12.htm 995497 - Disclosure - Cash, Cash Equivalents and Marketable Securities Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecurities Cash, Cash Equivalents and Marketable Securities Notes 12 false false R13.htm 995507 - Disclosure - Fair Value Measurements Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 13 false false R14.htm 995517 - Disclosure - Prepayments and Other Receivables Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosurePrepaymentsAndOtherReceivables Prepayments and Other Receivables Notes 14 false false R15.htm 995527 - Disclosure - Accrued Expenses and Other Current Liabilities Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities1 Accrued Expenses and Other Current Liabilities Notes 15 false false R16.htm 995537 - Disclosure - Shareholders' Equity Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureShareholdersEquity1 Shareholders' Equity Notes 16 false false R17.htm 995547 - Disclosure - Share-Based Compensation Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSharebasedCompensation Share-Based Compensation Notes 17 false false R18.htm 995557 - Disclosure - Segment Information Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSegmentInformation Segment Information Notes 18 false false R19.htm 995577 - Disclosure - Net Loss Per Ordinary Share Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureNetLossPerOrdinaryShare1 Net Loss Per Ordinary Share Notes 19 false false R20.htm 995597 - Disclosure - Commitments and Contingencies Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingencies1 Commitments and Contingencies Notes 20 false false R21.htm 995607 - Disclosure - Related Parties Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureRelatedParties Related Parties Notes 21 false false R22.htm 995627 - Disclosure - Subsequent Events Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 22 false false R23.htm 995637 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies1 23 false false R24.htm 995657 - Disclosure - Revenue (Tables) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureRevenueTables Revenue (Tables) Tables http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureRevenue 24 false false R25.htm 995667 - Disclosure - Cash, Cash Equivalents and Marketable Securities (Tables) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesTables Cash, Cash Equivalents and Marketable Securities (Tables) Tables http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecurities 25 false false R26.htm 995677 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureFairValueMeasurements 26 false false R27.htm 995687 - Disclosure - Prepayments and Other Receivables (Tables) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosurePrepaymentsAndOtherReceivablesTables Prepayments and Other Receivables (Tables) Tables http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosurePrepaymentsAndOtherReceivables 27 false false R28.htm 995697 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables Accrued Expenses and Other Current Liabilities (Tables) Tables http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities1 28 false false R29.htm 995707 - Disclosure - Share-Based Compensation (Tables) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSharebasedCompensationTables Share-Based Compensation (Tables) Tables http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSharebasedCompensation 29 false false R30.htm 995717 - Disclosure - Segment Information (Tables) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSegmentInformation 30 false false R31.htm 995737 - Disclosure - Net Loss Per Ordinary Share (Tables) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureNetLossPerOrdinaryShareTables Net Loss Per Ordinary Share (Tables) Tables http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureNetLossPerOrdinaryShare1 31 false false R32.htm 995757 - Disclosure - The Company - Additional Information (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureTheCompanyAdditionalInformationDetails The Company - Additional Information (Details) Details 32 false false R33.htm 995787 - Disclosure - FLAC Merger - Additional Information (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureFlacMergerAdditionalInformationDetails FLAC Merger - Additional Information (Details) Details 33 false false R34.htm 995797 - Disclosure - Revenue - License Revenue (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureRevenueLicenseRevenueDetails Revenue - License Revenue (Details) Details 34 false false R35.htm 995817 - Disclosure - Revenue - Additional Information - (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureRevenueAdditionalInformationDetails Revenue - Additional Information - (Details) Details 35 false false R36.htm 995827 - Disclosure - Cash, Cash Equivalents and Marketable Securities - Summary of Cash, Cash Equivalents and Marketable Securities (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureCashCashEquivalentsAndMarketableSecuritiesSummaryOfCashCashEquivalentsAndMarketableSecuritiesDetails Cash, Cash Equivalents and Marketable Securities - Summary of Cash, Cash Equivalents and Marketable Securities (Details) Details 36 false false R37.htm 995837 - Disclosure - Fair Value Measurements - Summary of Financial Liabilities Recognized at Fair Value on Recurring Basis (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfFinancialLiabilitiesRecognizedAtFairValueOnRecurringBasisDetails Fair Value Measurements - Summary of Financial Liabilities Recognized at Fair Value on Recurring Basis (Details) Details 37 false false R38.htm 995847 - Disclosure - Fair Value Measurements - Schedule of Estimated Fair Value of Derivative Earnout Liability (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfEstimatedFairValueOfDerivativeEarnoutLiabilityDetails Fair Value Measurements - Schedule of Estimated Fair Value of Derivative Earnout Liability (Details) Details 38 false false R39.htm 995857 - Disclosure - Fair Value Measurements - Summary of Reconciliation of Earnout Liability Measured on Recurring Basis Using Level 3 Inputs (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsSummaryOfReconciliationOfEarnoutLiabilityMeasuredOnRecurringBasisUsingLevel3InputsDetails Fair Value Measurements - Summary of Reconciliation of Earnout Liability Measured on Recurring Basis Using Level 3 Inputs (Details) Details 39 false false R40.htm 995867 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 40 false false R41.htm 995877 - Disclosure - Prepayments and Other Receivables - Schedule of Prepayments and Other Receivables (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosurePrepaymentsAndOtherReceivablesScheduleOfPrepaymentsAndOtherReceivablesDetails Prepayments and Other Receivables - Schedule of Prepayments and Other Receivables (Details) Details 41 false false R42.htm 995887 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) Details 42 false false R43.htm 995897 - Disclosure - Shareholders' Equity - Additional Information (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetails Shareholders' Equity - Additional Information (Details) Details 43 false false R44.htm 995907 - Disclosure - Share-Based Compensation - Additional Information (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSharebasedCompensationAdditionalInformationDetails Share-Based Compensation - Additional Information (Details) Details 44 false false R45.htm 995917 - Disclosure - Share-Based Compensation - Summary of Stock Options Outstanding (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSharebasedCompensationSummaryOfStockOptionsOutstandingDetails Share-Based Compensation - Summary of Stock Options Outstanding (Details) Details 45 false false R46.htm 995927 - Disclosure - Share-Based Compensation - Summary of Weighted Average Assumptions (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSharebasedCompensationSummaryOfWeightedAverageAssumptionsDetails Share-Based Compensation - Summary of Weighted Average Assumptions (Details) Details 46 false false R47.htm 995937 - Disclosure - Share-Based Compensation - Schedule of Restricted Stock Unit Activity (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSharebasedCompensationScheduleOfRestrictedStockUnitActivityDetails Share-Based Compensation - Schedule of Restricted Stock Unit Activity (Details) Details 47 false false R48.htm 995947 - Disclosure - Share-Based Compensation - Summary of Share-Based Payment Expense (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSharebasedCompensationSummaryOfSharebasedPaymentExpenseDetails Share-Based Compensation - Summary of Share-Based Payment Expense (Details) Details 48 false false R49.htm 995957 - Disclosure - Segment Information - Additional Information (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 49 false false R50.htm 995967 - Disclosure - Segment Information - Schedule of Adjusted Earnings/(Loss) Before Taxes for the Company's Single Segment (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureSegmentInformationScheduleOfAdjustedEarningslossBeforeTaxesForTheCompanysSingleSegmentDetails Segment Information - Schedule of Adjusted Earnings/(Loss) Before Taxes for the Company's Single Segment (Details) Details 50 false false R51.htm 995977 - Disclosure - Income Taxes - Schedule of Income Before Provision for Income Taxes (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureIncomeTaxesScheduleOfIncomeBeforeProvisionForIncomeTaxesDetails Income Taxes - Schedule of Income Before Provision for Income Taxes (Details) Details 51 false false R52.htm 996027 - Disclosure - Net Loss Per Ordinary Share - Summary of Basic And Diluted Net Loss Per Ordinary Share (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureNetLossPerOrdinaryShareSummaryOfBasicAndDilutedNetLossPerOrdinaryShareDetails Net Loss Per Ordinary Share - Summary of Basic And Diluted Net Loss Per Ordinary Share (Details) Details 52 false false R53.htm 996037 - Disclosure - Net Loss Per Ordinary Share - Summary of Potentially Dilutive Securities Have Been Excluded From The Computation Of Diluted Weighted-average Ordinary Shares Outstanding (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureNetLossPerOrdinaryShareSummaryOfPotentiallyDilutiveSecuritiesHaveBeenExcludedFromTheComputationOfDilutedWeightedaverageOrdinary Net Loss Per Ordinary Share - Summary of Potentially Dilutive Securities Have Been Excluded From The Computation Of Diluted Weighted-average Ordinary Shares Outstanding (Details) Details 53 false false R54.htm 996057 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.newamsterdampharma.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 54 false false All Reports Book All Reports nams-20250331.htm nams-20250331.xsd http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 false false